DIXON HUBARD FEINOUR & BROWN INC/VA

Holdings History for SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

Symbol: SUPN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2019		-0.77%	$0	0	-62,680	-100%	$51.30	Q1 2019
31 Dec 2018	0.77%	-0.32%	$2,082,000	62,680	-25,835	-29%	$33.22	Q4 2018
30 Sep 2018	1.2%	+0.01%	$4,457,000	88,515	+685	+0.78%	$50.35	Q3 2018
30 Jun 2018	1.5%	+1.5%	$5,257,000	87,830	+87,830	NEW	$59.85	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.